A detailed history of Levy Wealth Management Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Levy Wealth Management Group, LLC holds 6,452 shares of ABBV stock, worth $1.11 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
6,452
Previous 6,452 -0.0%
Holding current value
$1.11 Million
Previous $999,000 17.52%
% of portfolio
0.31%
Previous 0.28%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 23, 2024

BUY
$137.6 - $154.97 $1,376 - $1,549
10 Added 0.16%
6,452 $999,000
Q3 2023

Oct 24, 2023

BUY
$133.59 - $154.65 $1,068 - $1,237
8 Added 0.12%
6,442 $960,000
Q2 2023

Jul 21, 2023

BUY
$132.51 - $164.9 $1,192 - $1,484
9 Added 0.14%
6,434 $866,000
Q1 2023

May 04, 2023

BUY
$144.61 - $166.54 $1,156 - $1,332
8 Added 0.12%
6,425 $1.02 Million
Q4 2022

Feb 08, 2023

SELL
$138.31 - $165.87 $17,841 - $21,397
-129 Reduced 1.97%
6,417 $1.04 Million
Q3 2022

Oct 28, 2022

BUY
$134.21 - $153.93 $19,326 - $22,165
144 Added 2.25%
6,546 $879,000
Q2 2022

Jul 27, 2022

BUY
$137.62 - $174.96 $963 - $1,224
7 Added 0.11%
6,402 $981,000
Q1 2022

May 05, 2022

BUY
$131.98 - $163.75 $1,055 - $1,310
8 Added 0.13%
6,395 $1.04 Million
Q4 2021

Feb 10, 2022

BUY
$107.43 - $135.93 $966 - $1,223
9 Added 0.14%
6,387 $865,000
Q3 2021

Oct 26, 2021

BUY
$106.4 - $120.78 $638 - $724
6 Added 0.09%
6,378 $688,000
Q2 2021

Aug 10, 2021

BUY
$105.21 - $117.21 $1,472 - $1,640
14 Added 0.22%
6,372 $718,000
Q1 2021

May 10, 2021

BUY
$102.3 - $112.62 $1,636 - $1,801
16 Added 0.25%
6,358 $688,000
Q4 2020

Feb 10, 2021

BUY
$80.49 - $108.67 $510,467 - $689,185
6,342 New
6,342 $680,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Levy Wealth Management Group, LLC Portfolio

Follow Levy Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Levy Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Levy Wealth Management Group, LLC with notifications on news.